当前位置:首页 - 行情中心 - 宏源药业(301246) - 财务分析

宏源药业

(301246)

  

流通市值:55.05亿  总市值:129.48亿
流通股本:1.70亿   总股本:4.00亿

宏源药业(301246)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润1.44亿元,每股收益0.36元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益460758.04万元,未分配利润186927.59万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产628338.29万元,负债167580.25万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入703,525,713.021,939,468,837.261,317,076,113.48882,558,988.14
营业总成本543,865,867.351,794,917,960.561,292,835,287.81865,650,935.27
其他经营收益
营业利润183,627,386.63158,267,273.666,603,683.4747,965.97
利润总额164,865,777.42145,715,190.345,196,279.4-803,086.38
净利润144,197,566.58117,629,722.13-1,943,993.04-6,408,271.22
每股收益
其他综合收益----
综合收益总额144,197,566.58117,629,722.13-1,943,993.04-6,408,271.22
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计3,340,600,138.233,296,902,250.343,138,678,439.753,162,525,882.74
非流动资产:
非流动资产合计2,942,782,742.732,867,710,580.212,763,078,666.922,749,188,053.97
资产总计6,283,382,880.966,164,612,830.555,901,757,106.675,911,713,936.71
流动负债:
流动负债合计1,158,166,565.891,241,213,008.411,077,617,549.011,107,515,558.41
非流动负债:
非流动负债合计517,635,919.94464,573,085.24488,273,074.96473,530,267.87
负债合计1,675,802,485.831,705,786,093.651,565,890,623.971,581,045,826.28
所有者权益(或股东权益):
归属于母公司股东权益合计4,608,458,628.954,459,554,952.224,335,419,133.284,329,941,050.6
股东权益合计4,607,580,395.134,458,826,736.94,335,866,482.74,330,668,110.43
负债和股东权益合计6,283,382,880.966,164,612,830.555,901,757,106.675,911,713,936.71
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计269,357,413.631,119,623,900.72845,673,148.96524,553,808.39
经营活动现金流出小计279,848,926.511,304,585,926.861,031,063,070.06694,068,356.89
经营活动产生的现金流量净额-10,491,512.88-184,962,026.14-185,389,921.1-169,514,548.5
投资活动产生的现金流量:
投资活动现金流入小计432,374,202.495,389,464,409.324,186,480,447.332,621,806,486.69
投资活动现金流出小计631,000,870.275,630,093,034.644,828,292,020.472,963,945,483.6
投资活动产生的现金流量净额-198,626,667.78-240,628,625.32-641,811,573.14-342,138,996.91
筹资活动产生的现金流量:
筹资活动现金流入小计81,750,657.99583,099,426.01508,037,678.01381,042,716.38
筹资活动现金流出小计71,047,426.36351,752,085.3171,933,170.45110,912,950.35
筹资活动产生的现金流量净额10,703,231.63231,347,340.71336,104,507.56270,129,766.03
汇率变动对现金及现金等价物的影响-1,500,551.33-354,941.99581,007.55495,696.86
现金及现金等价物净增加额-199,915,500.36-194,598,252.74-490,515,979.13-241,028,082.52
期末现金及现金等价物余额187,672,624.92387,588,125.2891,670,398.89341,158,295.5
补充资料:
现金及现金等价物的净增加额--194,598,252.74--241,028,082.52
TOP↑